# Investor_Analytics_Dawa

This project demonstrates **investor-focused analytics** for a pharmaceutical company in Kenya.  

**Objectives:**  
- Provide insights on **drug revenue and profitability**  
- Analyze **market share per product**  
- Monitor **growth trends and sales forecasts**  
- Deliver data for **investor decision-making**  

**Skills demonstrated:** SQL, Revenue & Profit Analysis, Market Share Analytics, Forecasting, Investor Reporting  

**Drugs included (20):**  
1. Cefadroxil 500mg  
2. Diclofenac 50mg  
3. Metformin 500mg  
4. Amoxiclav 625mg  
5. Paracetamol 500mg  
6. Amlodipine 5mg  
7. Omeprazole 20mg  
8. Simvastatin 20mg  
9. Salbutamol 100mcg  
10. Captopril 25mg  
11. Azithromycin 500mg  
12. Clopidogrel 75mg  
13. Insulin Glargine 100IU  
14. Furosemide 40mg  
15. Levothyroxine 50mcg  
16. Hydrochlorothiazide 25mg  
17. Lisinopril 10mg  
18. Atorvastatin 20mg  
19. Metronidazole 400mg  
20. Cefuroxime 500mg  

**Queries covered:**  
1. Total revenue per drug  
2. Profit per drug  
3. Market share per drug  
4. Monthly revenue trend  
5. Profit margin per drug
